Invetx, Inc. — Form D
Invetx, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-11. The offering totals $55.5M, of which $55.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-04-11
- Form: D
- Accession: 0001567619-22-008337
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $55.5M
- Amount sold: $55.5M
- Investors: 10
- Date of first sale: 2022-03-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-441307
Issuer
- Name: Invetx, Inc.
- CIK: 0001805171
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 201 WASHINGTON STREET - STE 3930, BOSTON, MA, 02109
- Phone: 617-880-4592
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| JASON AKUS | Director | BOSTON, MA |
| Philip Austin | Director | Boston, MA |
| JOACHIM HASENMAIER | Director | BOSTON, MA |
| JURGEN HORN | Director | BOSTON, MA |
| Peter Lee | Director | Chatsworth, CA |
| JURGEN HORN | Executive Officer | BOSTON, MA |
Other filings by this issuer (1)
More